
Last update at 2026-06-22T19:51:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown |
|---|
Sector: None Industry: None
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher CDR (CAD Hedged) |
-0.21 1.25% | 16.61 | 28.70 | 20.49 | 4.30 | 3.53 | 5.03 | 19.49 |
| AVGO Broadcom CDR (CAD Hedged) |
-0.71 4.51% | 15.04 | 12.44 | 5.73 | 4.54 | 3.78 | 28.65 | 52.40 |
| WMT Walmart CDR (CAD Hedged) |
0.11 0.22% | 49.08 | 45.06 | 41.67 | 1.38 | 9.84 | 1.51 | 23.16 |
| LLY Eli Lilly CDR (CAD Hedged) |
0.26 0.66% | 39.62 | 37.91 | 25.77 | 12.03 | 29.35 | 12.92 | 26.57 |
| JPM JPMorgan CDR (CAD Hedged) |
0.54 1.29% | 42.50 | 14.46 | 14.03 | 4.49 | 2.36 | 6.97 |
| Name | Title | Year Born |
|---|---|---|
| Mr. Marc N. Casper | Chairman, President & CEO | 1968 |
| Mr. Stephen Williamson | Senior VP & CFO | 1967 |
| Mr. Michel Lagarde | Executive VP & COO | 1975 |
| Mr. Frederick M. Lowery | Executive VP and President of Laboratory Product & BioProduction | 1971 |
| Mr. Gianluca Pettiti | Executive VP and President of Life Science, Diagnostics & Applied | 1979 |
| Mr. Joseph R. Holmes | VP & Chief Accounting Officer | 1979 |
| Mr. Ryan J. Snyder | Senior VP & Chief Information Officer | NA |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer | NA |
| Mr. Rafael Tejada | Vice President of Investor Relations | NA |
| Mr. Thomas Bailey Shropshire Jr. | Senior VP and General Counsel | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.